$BNGO
Bionano Genomics, Inc. Stock $bngo

$bngo Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000141169022000021 Filed on August 04, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$7.221M	$6.670M	$5.696M
YoY Change	55.12%	72.98%	79.8%
Cost Of Revenue	$5.412M	$5.199M	$4.835M
YoY Change	54.58%	115.1%	127.53%
Gross Profit	$1.809M	$1.471M	$861.0K
YoY Change	56.76%	2.22%	-17.45%
Gross Profit Margin	25.05%	22.05%	15.12%
Selling, General & Admin	$21.22M	$21.78M	$20.28M
YoY Change	38.42%	57.52%	112.81%
% of Gross Profit	1172.8%	1480.83%	2355.05%
Research & Development	$12.74M	$11.77M	$10.53M
YoY Change	95.88%	187.98%	293.09%
% of Gross Profit	704.37%	799.93%	1222.65%
Depreciation & Amortization	$2.431M	$2.353M	$2.210M
YoY Change	362.17%	357.78%	393.3%
% of Gross Profit	134.38%	159.96%	256.68%
Operating Expenses	$33.96M	$33.55M	$30.80M
YoY Change	55.54%	87.27%	152.37%
Operating Profit	-$32.15M	-$32.08M	-$29.94M
YoY Change	55.47%	94.7%	168.23%
Interest Expense	$73.00K	$74.00K	$77.00K
YoY Change	170.37%	-75.33%	-87.17%
% of Operating Profit
Other Income/Expense, Net	$368.0K	-$38.00K	$0.00
YoY Change	-1020.0%	-98.35%	-100.0%
Pretax Income	-$31.78M	-$32.12M	-$29.94M
YoY Change	53.4%	71.04%	201.21%
Income Tax	$28.00K	$41.00K	$9.000K
% Of Pretax Income
Net Earnings	-$31.81M	-$32.16M	-$29.95M
YoY Change	53.27%	71.18%	201.12%
Net Earnings / Revenue	-440.51%	-482.13%	-525.84%
Basic Earnings Per Share	-$0.11	-$0.11	-$0.11
Diluted Earnings Per Share	-$0.11	-$0.11	-$0.11
COMMON SHARES
Basic Shares Outstanding	290.1M shares	285.6M shares	284.6M shares
Diluted Shares Outstanding	289.7M shares	285.6M shares	284.6M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$180.2M	$187.4M	$216.4M
YoY Change	-44.72%	-43.65%	-40.24%
Cash & Equivalents	$28.20M	$27.20M	$24.00M
Short-Term Investments	$152.0M	$160.2M	$192.4M
Other Short-Term Assets	$7.132M	$3.509M	$4.110M
YoY Change	80.01%	108.5%	28.44%
Inventory	$25.05M	$20.59M	$16.27M
Prepaid Expenses
Receivables	$5.829M	$4.851M	$5.514M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$218.2M	$216.3M	$242.4M
YoY Change	-36.21%	-36.75%	-34.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.86M	$13.92M	$12.66M
YoY Change	85.4%	128.85%	118.07%
Goodwill	$56.47M	$56.25M	$56.25M
YoY Change	687.2%	684.25%	684.25%
Intangibles	$22.59M	$24.01M	$25.42M
YoY Change	1724.31%	1722.7%	1721.2%
Long-Term Investments
YoY Change
Other Assets	$802.0K	$841.0K	$798.0K
YoY Change	24.34%	211.48%	239.57%
Total Long-Term Assets	$105.5M	$105.3M	$105.9M
YoY Change	499.1%	609.14%	624.51%
TOTAL ASSETS
Total Short-Term Assets	$218.2M	$216.3M	$242.4M
Total Long-Term Assets	$105.5M	$105.3M	$105.9M
Total Assets	$323.7M	$321.6M	$348.2M
YoY Change	-10.0%	-9.88%	-9.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.407M	$7.695M	$6.590M
YoY Change	19.45%	105.47%	198.33%
Accrued Expenses	$11.74M	$7.760M	$8.936M
YoY Change	24.7%	18.65%	91.8%
Deferred Revenue	$976.0K	$1.180M	$1.107M
YoY Change	137.47%	165.17%	267.77%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$288.0K	$292.0K	$296.0K
YoY Change
Total Short-Term Liabilities	$33.50M	$27.91M	$18.66M
YoY Change	89.24%	160.09%	160.27%
LONG-TERM LIABILITIES
Long-Term Debt	$3.626M	$3.632M	$3.638M
YoY Change			-75.53%
Other Long-Term Liabilities	$4.830M	$5.278M	$14.73M
YoY Change	1981.9%	2377.93%	14629.0%
Total Long-Term Liabilities	$8.456M	$8.910M	$18.37M
YoY Change	3544.83%		23.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$33.50M	$27.91M	$18.66M
Total Long-Term Liabilities	$8.456M	$8.910M	$18.37M
Total Liabilities	$41.96M	$36.82M	$37.03M
YoY Change	131.9%	236.45%	67.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$310.0M	-$278.2M	-$246.1M
YoY Change	60.5%	61.37%	60.17%
Common Stock	$593.6M	$564.9M	$558.9M
YoY Change	10.98%	8.99%	8.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$281.7M	$284.7M	$311.2M
YoY Change
Total Liabilities & Shareholders Equity	$323.7M	$321.6M	$348.2M
YoY Change	-10.0%	-9.88%	-9.52%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$31.81M	-$32.16M	-$29.95M
YoY Change	53.27%	71.18%	201.12%
Depreciation, Depletion And Amortization	$2.431M	$2.353M	$2.210M
YoY Change	362.17%	357.78%	393.3%
Cash From Operating Activities	-$29.47M	-$28.33M	-$32.49M
YoY Change	47.5%	128.06%	133.7%
INVESTING ACTIVITIES
Capital Expenditures	-$290.0K	-$469.0K	-$982.0K
YoY Change	8.21%	737.5%	-4191.67%
Acquisitions			-$694.0K
YoY Change
Other Investing Activities	$8.243M	$31.71M	$32.95M
YoY Change	-104.45%	25065.87%
Cash From Investing Activities	$7.953M	$31.24M	$31.96M
YoY Change	-104.28%	44528.57%	-133283.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	22.65M	203.0K	$7.000K
YoY Change	64.54%	-101.18%	-100.0%
NET CHANGE
Cash From Operating Activities	-29.47M	-28.33M	-$32.49M
Cash From Investing Activities	7.953M	31.24M	$31.96M
Cash From Financing Activities	22.65M	203.0K	$7.000K
Net Change In Cash	1.131M	3.111M	-$523.0K
YoY Change	-100.59%	-110.54%	-100.16%
FREE CASH FLOW
Cash From Operating Activities	-$29.47M	-$28.33M	-$32.49M
Capital Expenditures	-$290.0K	-$469.0K	-$982.0K
Free Cash Flow	-$29.18M	-$27.86M	-$31.51M
YoY Change	48.03%	125.3%	126.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001411690
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P6M
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38613
	dei	Entity Registrant Name EntityRegistrantName	Bionano Genomics, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1756290
	dei	Entity Address Address Line1 EntityAddressAddressLine1	9540 Towne Centre Drive, Suite 100
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92121
	dei	City Area Code CityAreaCode	858
	dei	Local Phone Number LocalPhoneNumber	888-7600
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	290139940	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27159000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24571000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	160178000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	226041000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	463000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	690000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4851000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4934000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	20591000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	12387000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3509000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4481000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	216288000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	272414000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13923000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10318000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6431000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6691000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3810000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3926000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	24005000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	26842000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	56254000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	56160000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	841000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	749000	usd
CY2022Q2	us-gaap	Assets Assets	321552000	usd
CY2021Q4	us-gaap	Assets Assets	377100000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	7695000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9696000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7760000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9694000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1180000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	684000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1757000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1467000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	292000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	299000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	9224000	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	27908000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21840000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5075000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5288000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3632000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3642000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	9066000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	203000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	146000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	36818000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	39982000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	290061000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	290061000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	289602000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	289602000	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	29000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	29000	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	564852000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	553747000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-278229000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-216119000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1918000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-539000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	284734000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	337118000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	321552000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	377100000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6670000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3856000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12366000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7024000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5199000	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2417000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10034000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4542000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11767000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4086000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22296000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6765000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21783000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13829000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	42060000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	23357000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	33550000	usd
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	17915000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	64356000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	30122000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-32079000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-16476000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-62024000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-27640000	usd
CY2022Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	192000	usd
CY2021Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	58000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	301000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	123000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	74000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	268000	usd
	us-gaap	Interest Expense InterestExpense	151000	usd
	us-gaap	Interest Expense InterestExpense	871000	usd
CY2022Q2	bngo	Gain Loss On Forgiveness Of Paycheck Protection Program Loan GainLossOnForgivenessOfPaycheckProtectionProgramLoan	0	usd
CY2021Q2	bngo	Gain Loss On Forgiveness Of Paycheck Protection Program Loan GainLossOnForgivenessOfPaycheckProtectionProgramLoan	0	usd
	bngo	Gain Loss On Forgiveness Of Paycheck Protection Program Loan GainLossOnForgivenessOfPaycheckProtectionProgramLoan	0	usd
	bngo	Gain Loss On Forgiveness Of Paycheck Protection Program Loan GainLossOnForgivenessOfPaycheckProtectionProgramLoan	1775000	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2076000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2076000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-156000	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-188000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-29000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-38000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2301000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-38000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	50000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15000	usd
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1078000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-32117000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18777000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-62062000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28718000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	41000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-32158000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-18786000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-62112000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28733000	usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	285554000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	285554000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	278898000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	278898000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	285086000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	285086000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	271460000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	271460000	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-32158000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-18786000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-62112000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28733000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-281000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1379000	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-32439000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18786000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-63491000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28733000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	35082000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	333000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	371000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	327486000	usd
CY2021Q1	bngo	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	9393000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-9947000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	362718000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	89000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1758000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	65000	usd
CY2021Q2	bngo	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	22000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-18786000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	345866000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	337118000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	15000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5102000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-29952000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1098000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	311185000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	136000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5777000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	75000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-32158000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-281000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	284734000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-62112000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28733000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4475000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	964000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	117000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	usd
	us-gaap	Accretion Expense AccretionExpense	551000	usd
	us-gaap	Accretion Expense AccretionExpense	0	usd
	bngo	Noncash Interest Expense NoncashInterestExpense	337000	usd
	bngo	Noncash Interest Expense NoncashInterestExpense	0	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	0	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	383000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10878000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2129000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	158000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
	bngo	Gain Loss On Forgiveness Of Paycheck Protection Program Loan GainLossOnForgivenessOfPaycheckProtectionProgramLoan	0	usd
	bngo	Gain Loss On Forgiveness Of Paycheck Protection Program Loan GainLossOnForgivenessOfPaycheckProtectionProgramLoan	1775000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2076000	usd
	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	204000	usd
	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-24000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	63000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12095000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3605000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-186000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-400000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2072000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	816000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1477000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1085000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-60826000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26323000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-694000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	bngo	Payments For Property And Equipment PaymentsForPropertyAndEquipment	371000	usd
	bngo	Payments For Property And Equipment PaymentsForPropertyAndEquipment	76000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	29541000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	93475000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	1080000	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	0	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	27000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	126000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	63204000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	50000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	17010000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	17000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	328635000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1149000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	75000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	65000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	152000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9837000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	210000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	320378000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2588000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	294105000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24571000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38449000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2013000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27159000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	332554000	usd
	us-gaap	Interest Paid Net InterestPaidNet	139000	usd
	us-gaap	Interest Paid Net InterestPaidNet	487000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	695000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	422000	usd
	bngo	Transfer Of Instruments And Servers To Property And Equipment From Inventory TransferOfInstrumentsAndServersToPropertyAndEquipmentFromInventory	3890000	usd
	bngo	Transfer Of Instruments And Servers To Property And Equipment From Inventory TransferOfInstrumentsAndServersToPropertyAndEquipmentFromInventory	2035000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	517000	usd
	bngo	Gain Loss On Forgiveness Of Paycheck Protection Program Loan GainLossOnForgivenessOfPaycheckProtectionProgramLoan	0	usd
	bngo	Gain Loss On Forgiveness Of Paycheck Protection Program Loan GainLossOnForgivenessOfPaycheckProtectionProgramLoan	1775000	usd
	bngo	Warrant Exercise Non Cash WarrantExerciseNonCash	0	usd
	bngo	Warrant Exercise Non Cash WarrantExerciseNonCash	129000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27200000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	160200000	usd
CY2022Q2	bngo	Working Capital WorkingCapital	188400000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	32302000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14731000	shares
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6670000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3856000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12366000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7024000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6670000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3856000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12366000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7024000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1400000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.593
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.326
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.081
CY2022Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	200000	usd
CY2021Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	500000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	200000	usd
CY2022Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	5314000	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	5624000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	463000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	690000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4851000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4934000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28380000	usd
CY2022Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	837000	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	745000	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	19754000	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11642000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	20591000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	12387000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28380000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4375000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24005000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1538000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	26842000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4861000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4529000	usd
CY2022Q2	bngo	Accrued Inventory Current AccruedInventoryCurrent	1238000	usd
CY2021Q4	bngo	Accrued Inventory Current AccruedInventoryCurrent	1073000	usd
CY2022Q2	us-gaap	Deposit Liability Current DepositLiabilityCurrent	73000	usd
CY2021Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	826000	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	722000	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	677000	usd
CY2022Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	0	usd
CY2021Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	1011000	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	368000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	288000	usd
CY2022Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	175000	usd
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	175000	usd
CY2022Q2	bngo	Accrued Clinical Study Fees Current AccruedClinicalStudyFeesCurrent	169000	usd
CY2021Q4	bngo	Accrued Clinical Study Fees Current AccruedClinicalStudyFeesCurrent	1000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	154000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1114000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7760000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9694000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	300000	usd
	us-gaap	Interest Expense InterestExpense	900000	usd
CY2021Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	33400000	shares
CY2021Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	38300000	shares
CY2021Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	3.05
CY2021Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	6.00
CY2021Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	101500000	usd
CY2021Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	229600000	usd
CY2020Q3	bngo	Sale Of Stock Authorized Amount To Be Issued SaleOfStockAuthorizedAmountToBeIssued	125000000	usd
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	27000000	shares
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	38000000	usd
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2300000	shares
CY2021Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	6.15
CY2021Q3	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	13900000	usd
CY2021Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	600000	usd
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4356000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.96
CY2021	bngo	Class Of Warrant Or Right Weighted Average Remaining Contractual Term Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageRemainingContractualTermOfWarrantsOrRights	P1Y9M3D
CY2021Q4	bngo	Class Of Warrant Or Right Aggregate Intrinsic Value Of Warrants Or Rights ClassOfWarrantOrRightAggregateIntrinsicValueOfWarrantsOrRights	785000	usd
	bngo	Class Of Warrant Or Right Number Of Securities Granted In Period ClassOfWarrantOrRightNumberOfSecuritiesGrantedInPeriod	0	shares
	bngo	Class Of Warrant Or Right Number Of Securities Exercised In Period ClassOfWarrantOrRightNumberOfSecuritiesExercisedInPeriod	0	shares
	bngo	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised In Period ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercisedInPeriod	0
	bngo	Class Of Warrant Or Right Aggregate Intrinsic Value Exercised In Period Of Warrants Or Rights ClassOfWarrantOrRightAggregateIntrinsicValueExercisedInPeriodOfWarrantsOrRights	0	usd
	bngo	Class Of Warrant Or Right Number Of Securities Canceled In Period ClassOfWarrantOrRightNumberOfSecuritiesCanceledInPeriod	0	shares
	bngo	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Cancelled In Period ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsCancelledInPeriod	0
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4356000	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.96
	bngo	Class Of Warrant Or Right Weighted Average Remaining Contractual Term Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageRemainingContractualTermOfWarrantsOrRights	P1Y3M7D
CY2022Q2	bngo	Class Of Warrant Or Right Aggregate Intrinsic Value Of Warrants Or Rights ClassOfWarrantOrRightAggregateIntrinsicValueOfWarrantsOrRights	246000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12765000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.97
	bngo	Lessee Estimated Incremental Borrowing Rate LesseeEstimatedIncrementalBorrowingRate	0.07
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y10M24D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	7891000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	12797000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.11
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	270000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.59
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	302000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1708000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.00
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	23584000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.47
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y29D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2053000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	4976000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.90
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y11M15D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	1327000	usd
CY2021	bngo	Lessee Estimated Incremental Borrowing Rate LesseeEstimatedIncrementalBorrowingRate	0.07
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.17
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.33
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5777000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1758000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10879000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2129000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.028
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.011
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.021
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.011
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.706
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.804
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.702
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.804
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M12D
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1467000	usd
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	500000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6431000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6691000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1757000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5075000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5288000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	6832000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6755000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	1000000	usd
CY2021Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	300000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	500000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3810000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3926000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	292000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	299000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3632000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3642000	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	3924000	usd
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	3941000	usd
CY2022Q2	bngo	Finance Lease Expense FinanceLeaseExpense	100000	usd
	bngo	Finance Lease Expense FinanceLeaseExpense	300000	usd
	bngo	Finance Lease Expense FinanceLeaseExpense	0	usd
CY2022Q2	bngo	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	0	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1036000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	158000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2149000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	322000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2219000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	330000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2305000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	338000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	232000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	347000	usd
CY2022Q2	bngo	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	5949000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7941000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	7444000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1109000	usd
CY2022Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	3520000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	6832000	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	3924000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	47	security
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	57	security
	bngo	Contingent Consideration Milestone Payment ContingentConsiderationMilestonePayment	10000000	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	200000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	300000	usd

Files In Submission

Name	View Source	Status
0001411690-22-000021-index-headers.html	Edgar Link	pending
0001411690-22-000021-index.html	Edgar Link	pending
0001411690-22-000021.txt	Edgar Link	pending
0001411690-22-000021-xbrl.zip	Edgar Link	pending
bngo-20220630.htm	Edgar Link	pending
bngo-20220630.xsd	Edgar Link	pending
bngo-20220630xexx311.htm	Edgar Link	pending
bngo-20220630xexx312.htm	Edgar Link	pending
bngo-20220630xexx321.htm	Edgar Link	pending
bngo-20220630_cal.xml	Edgar Link	unprocessable
bngo-20220630_def.xml	Edgar Link	unprocessable
bngo-20220630_htm.xml	Edgar Link	completed
bngo-20220630_lab.xml	Edgar Link	unprocessable
bngo-20220630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNGO
Bionano Genomics, Inc. Stock $bngo

2022 Q3 Form 10-Q Financial Statement

#000141169022000021 Filed on August 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNGO Bionano Genomics, Inc. Stock $bngo

2022 Q3 Form 10-Q Financial Statement

#000141169022000021 Filed on August 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNGO
Bionano Genomics, Inc. Stock $bngo